Prolonged retention of prophylactic pancreatic stents is not associated with increased complications
| Autor: | Georg Dultz, Stefan Zeuzem, Jörg Bojunga, Mireen Friedrich-Rust, Ludmila Gerber |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Endocrinology Diabetes and Metabolism medicine.medical_treatment Pancreatic stent Young Adult 03 medical and health sciences Postoperative Complications 0302 clinical medicine Risk Factors Humans Medicine cardiovascular diseases Aged Aged 80 and over Cholangiopancreatography Endoscopic Retrograde Hepatology medicine.diagnostic_test business.industry Gastroenterology Pancreatic Diseases Stent Retrospective cohort study Middle Aged equipment and supplies medicine.disease Endoscopy Surgery Stenosis surgical procedures operative 030220 oncology & carcinogenesis Cohort Pancreatitis Female Stents 030211 gastroenterology & hepatology business Complication |
| Zdroj: | Pancreatology. 19:39-43 |
| ISSN: | 1424-3903 |
| DOI: | 10.1016/j.pan.2018.11.011 |
| Popis: | Objectives The risk of post-ERCP pancreatitis (PEP) can be reduced effectively by the placement of a self dislodging pancreatic stent. The present study analyzed whether a prolonged interval until stent passage evaluation and removal of retained stents is associated with an increased risk for clinically relevant complications. Methods In the retrospective study 182 patients receiving a pancreatic stent for PEP prophylaxis were included and clinical data and complications until documented spontaneous stent dislodgement or removal were analyzed. Results The main indication for ERCP was choledocholithiasis (40.1%) followed by malignant stenosis (30.8%). Stent passage evaluation was performed in 34.1% at day 1–4, 23.6% at day 5–10, 17.6% at day 11–28 and 24.7% at day >28. PEP occurred in 13.1% of patients with no case of severe PEP. No association between PEP and day of stent passage evaluation (p = 0.719), retention of the pancreatic stent at time of evaluation (0.867) or prolonged stent retention >10 days (0.234) was observed. Only the duration of the procedure was associated with risk for PEP (p = 0.037). Besides PEP only one clinically relevant complication was observed in the cohort (0.5%) which was a late possibly stent related pancreatitis at day 9 after the procedure that resolved completely. Conclusions A prolonged interval for stent passage evaluation and stent retention is not associated with an increase of clinically relevant complications. A later evaluation and extraction of retained stents might be acceptable in selected cases where an additional endoscopic procedure can be saved due to a planned follow-up endoscopy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect